Comparison of Low Osmolar ORS and ReSoMal for Treating Acute Watery Diarrhea in Severely Malnourished Children Aged 6 Months to 5 Years
Comparison of Efficacy and Side Effect of Low Osmolar Oral Rehydration Solution Versus Oral Rehydration Solution For Malnourished Children (ReSoMal) in Management of Acute Watery Diarrhea in Severe Malnourished Children
1 other identifier
interventional
72
1 country
1
Brief Summary
Acute watery diarrhea is a common and serious health issue in children, especially in those who are severely malnourished. These children are at a much higher risk of complications such as dehydration, electrolyte imbalances, and even death. Oral Rehydration Solutions (ORS) are a widely used treatment to prevent and correct dehydration in such children. However, there are different types of ORS, and it is still unclear which one is more effective and safer for use in severely malnourished children. This clinical study is being conducted at The Children's Hospital, Lahore, to compare two different types of ORS: low osmolar ORS and ReSoMal (a special rehydration solution designed for malnourished children). The aim is to determine which solution is more effective in correcting low potassium levels (a common problem in these children) and to identify which one has fewer side effects, particularly problems like low or high sodium levels that can be dangerous. A total of 72 children between 6 months and 5 years of age, all diagnosed with severe malnutrition and mild to moderate dehydration due to acute watery diarrhea, will be included in the study. They will be randomly assigned to receive either low osmolar ORS or ReSoMal. Blood tests will be done before and after the treatment to check for changes in electrolyte levels. The frequency of diarrhea and the child's overall response to treatment will also be recorded. The hypothesis of this study is that there is a significant difference in both effectiveness and side effects between the two ORS solutions. The results of this study will help doctors choose the safest and most effective ORS for treating diarrhea in severely malnourished children, improving care and potentially saving lives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2025
CompletedFirst Submitted
Initial submission to the registry
June 10, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2025
CompletedJune 18, 2025
June 1, 2025
5 months
June 10, 2025
June 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correction of Hypokalemia After 24 Hours of Oral Rehydration
This outcome assesses the proportion of participants whose serum potassium levels normalize after 24 hours of treatment with either low osmolar ORS or ReSoMal. Hypokalemia is defined as serum potassium \<3.5 mmol/L. Correction is considered achieved if serum potassium rises to ≥3.5 mmol/L without requiring intravenous potassium supplementation.
24 hours after initiation of oral rehydration therapy
Secondary Outcomes (1)
Incidence of Hyponatremia and Hypernatremia After 24 Hours of Oral Rehydration
24 hours after initiation of oral rehydration therapy
Study Arms (2)
Group Low Osmolar ORS
EXPERIMENTALReceived low osmolar oral rehydration solution (ORS) with an osmolarity of 245 mmol/L and sodium 75 mmol/L, administered orally according to WHO guidelines for rehydration in diarrhea.
Group ReSoMal
ACTIVE COMPARATORReceived ReSoMal oral rehydration solution specifically formulated for malnourished children, with lower sodium and higher potassium content, administered orally.
Interventions
Composition: Na⁺ 75 mmol/L, K⁺ 20 mmol/L, Cl- 65 mmol/L, citrate 10 mmol/L, glucose 75 mmol/L; osmolarity 245 mmol/L. Administered orally in rehydration regimen over 24 hours.
Composition: Na⁺ 45 mmol/L, K⁺ 40 mmol/L, Cl- 76 mmol/L, citrate 7 mmol/L, glucose 125 mmol/L, Mg 6 mmol/L, Zn 300 µmol/L, Cu 45 µmol/L; osmolarity 300 mmol/L. Administered orally over 24 hours according to rehydration protocol.
Eligibility Criteria
You may qualify if:
- Children aged 6 months to 5 years.
- Both male and female.
- Children presenting with acute watery diarrhea.
- Children have mild to moderate dehydration.
- Children have serum sodium (135-145 mEq/L) and serum Potassium (2.5-3.4 mEq/L).
- Presence of severe malnutrition, defined as weight-for-length ≤ 3 standard deviations from the median of the World Health Organization (WHO) growth standards or mid-upper arm circumference (MUAC) \<115 mm.
- Children tolerating oral fluid.
- Parent or guardian willing and able to provide informed consent for participation.
You may not qualify if:
- Critically ill children with shock, history of not passed urine for 6 h, convulsions and electrolyte abnormality requiring intravenous (IV) for severe dehydration.
- History of chronic gastrointestinal disorders, such as inflammatory bowel disease or celiac disease.
- Received antibiotics within 48 hours before enrollment.
- Children having any systemic illness requiring hospitalization or specific treatment, such as sepsis or pneumonia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Of Child Health Sciences, Lahore
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sadaf Sumreen
University Of Child Health Sciences, Lahore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 10, 2025
First Posted
June 18, 2025
Study Start
February 10, 2025
Primary Completion
July 10, 2025
Study Completion
July 10, 2025
Last Updated
June 18, 2025
Record last verified: 2025-06